Triple-negative breast cancer vaccine shows promise in early clinical trial

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the cancer from recurring or possibly prevent it entirely.
Yahoo

First person in the world to get the breast cancer vaccine says it's changed her life. Here's how it works.

Jennifer Davis is the first person to receive the breast cancer vaccine as part of a clinical trial. (Photo illustration: Yahoo News; photos: Getty Images) Finding a cure for cancer has been the holy ...
News Medical

PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer

Patient-derived xenografts (PDX) may accurately predict early recurrence and survival outcomes in triple negative breast cancer (TNBC), offering a potential tool for tailoring treatment strategies to ...
Yahoo

Wash U vaccine trial shows promising data in preventing breast cancer recurrence

ST. LOUIS – A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer Center just released the results of a clinical trial showing a ...
Medscape

Debate Over? Data Support Adjuvant Carboplatin in Early TNBC

Adjuvant carboplatin added to standard anthracycline/taxane chemotherapy significantly improves outcomes in early ...
Monthly Prescribing Reference

Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer

Improved 3-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen. HealthDay News — For patients with operative triple-negative breast cancer, a multigene signature ...
Los Angeles Times

Triple-Negative Breast Cancer (TNBC): Understanding Diagnosis and Treatment

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

How to identify and treat triple-negative breast cancer — a rare but aggressive form of cancer

Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.

Cleveland Clinic unveils first phase results from breast cancer vaccine trial

According to a Cleveland Clinic-issued statement, researchers with the institution have announced the final results of a ...
Nasdaq

Merck’s KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)

KEYTRUDA in combination with chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery for patients with hormone receptor-negative and human ...
Cure Today

Low ctDNA Levels May Show Longer Recurrence-Free Interval in Breast Cancer

The ZEST trial, a phase 3 study on MRD-guided therapy in breast cancer, was terminated early due to low randomization rates. ctDNA was most frequently detected within six months post-treatment, ...
AOL

First person in the world to get the breast cancer vaccine says it's changed her life. Here's how it works.

Finding a cure for cancer has been the holy grail in medicine for years. With the exception of the only two cancer vaccines currently available — one for HPV, strains of which can cause cancer, ...